The PSCI Fall Meeting 2025 took place for the first-time in China, marking a significant milestone for the PSCI.

Members from around the globe attended in-person (35) and virtually (80) at AstraZeneca in Shanghai to present on key projects, hear updates from the Board and Committees, and consider how the PSCI can deepen its support for the pharmaceutical industry in China. We were pleased to welcome one Supplier Partner in person, as well as meet with 6 prospective Supplier Partners all interested in learning more about collaboration.

Read below for highlights from the two-day event. Many thanks to all our Members, Partners, and Supplier Partners who presented and attended.

Day 1

• Tony Pusic, Senior Vice President Asia Pacific & International, AstraZeneca welcome attendees and shared the company’s own priorities for sustainability.
• Xuegong Wang, Vice President of CPEA, a long-standing partner of the PSCI in China, shared key trends and insights into the Chinese pharmaceutical market. CPEA is highly regarded industry association that brings together pharmaceutical companies to discuss policy, standards, best practices, and industry developments.
• A session hosted by the China Sub-team on how the PSCI can continue to support suppliers in China and build our brand as a value-creating organizations for the Chinese pharma and healthcare industry.
• Rincy Joseph and Dorota Wiacek, project leads for the Link 2.0 platform, presented our incoming digital platform, now being populated and launching for member use on Q1 2026. Watch this space for further announcements.
• Ranjana Ganguly, Aditya Shirodkar, and Rohit Virmani shared the successes of the PSCI’s engagement in India.
• The PSCI Board closed Day 1 with our Annual General Meeting, announcing the newly elected Board members and providing financial and other strategic updates.

Day 2

• Enric Bosch presented an update on projects funded by the PSCI this year, which aim to create impact for suppliers and leverage our collective voice and scale. We also heard from Olivia Li on the recently approved Worker Voice project.
• Ryan Wang from Wuxi Biologics, introduced their recent Green CRDMO Whitepaper.
• Deirdre O’Reilly, Ranjana Ganguly, Germano D’Arasmo, Vijaya Kumar, Sarah Jones and Matthew Thomas of the Health & Safety Topic Team spoke on the critical importance of Health & Safety in the supply chain and the PSCI’s approach on reducing and mitigating critical incidents.
• Birgit Skuballa and Dorota Wiacek presented the latest Audit Findings Analysis Report, our annual analysis of PSCI audits on the platform that highlight key findings, regional differences, and insights within the supply chain.
• Warren Bird and Wenjia Xu then joined Birgit Skuballa and Dorota Wiacek to explore how tools like AI and others can support capability building, linking audit findings directly to PSCI resources.
• Devin Carsdale, Bridget Ferrari, Sandra Matamoros, Diana Killian, and Lucy Latham shared the successes of the PSCI’s first Decarbonization Summit and plans for what comes next.
• Rob Williams and Deidre O’Reilly closed the day reflecting on the PSCI’s partnerships for impact with groups like the CPHI Sustainability Collective and Sustainable Markets Initiative, and discussed how the PSCI should grow its Member and Supplier Partner base in China and Asia more broadly.

The WHO Alliance for Transformative Action on Climate Change has just published a new guidance: Decarbonizing the healthcare supply chain - strategic actions for health systems.

Overview
This report highlights practical actions for health systems to decarbonize their supply chain, depending on their local context and priorities. It outlines two complementary approaches: accelerating supplier decarbonization through procurement and optimizing demand and usage of supplies.

The report encourages better understanding of supply chain hotspots, partnership working and international alignment, while also discussing the key steps that will lead to the most transformative action moving forward. These approaches are illustrated by real-world ‘implementation examples’ embedded in the report. The PSCI's resources and work are mentioned in this report.

Read the report here.

The report was co-authored by NHS England, the WHO, Australian Government Department of Health, Disability and Ageing; Health Service Executive, Ireland; Ministry of Health, France; Ministry of Health, Germany; and Norwegian Hospital Procurement Trust, as part of an ATACH Task Team.

Attend the launch webinar
Join the live event at COP30 at 09.00-10.00 (BRT) Friday 21st November at the Health Pavilion. This event will include a discussion of key approaches to healthcare supply chain decarbonisation, raising awareness, inspiring action and accelerating global efforts to decarbonize healthcare. We warmly invite you to join in person or via the livestream here.

THE PSCI PRESENTS ITS ANNUAL PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS INTO SUPPLIER RISKS, TRENDS, AND AREAS FOR IMPROVEMENT ACROSS THE PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.

Pharmaceutical and healthcare companies run thousands of audits of their suppliers’ sites annually. Audits typically require between two to four days of focused, on-site effort from both the auditor and the supplier. PSCI members work together to share these audits, in support of greater transparency and valuable efficiencies that benefit both members and suppliers.

This report shares our analysis of findings from PSCI audits available on our platform. Each year, we review these in line with the PSCI Principles to identify trends, highlight improvements, and share recommendations. PSCI work with member companies, suppliers, and regional partners to turn analysis into practical guidance, training, and peer learning that suppliers can implement quickly. Overall, this analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry and suggests where collaborative efforts will have the greatest impact, guiding us on developing targeted resources and trainings.

This year’s report analyzes 2,046 findings from 228 supplier audits uploaded to the PSCI platform in 2024. These findings are categorised into 428 Governance & Management Systems findings, 26 Ethics findings, 273 Human Rights findings, 1,098 Health & Safety findings, and 221 Environment findings, offering a comprehensive overview of supplier practices and opportunities for improvement. The report includes a summary of findings across key topics, as well as a regional analysis looking at patterns across China, India, US, Western Europe, and other regions represented in this year’s uploads, presenting recommended actions for suppliers.

What’s new this year?

• A new five-year trend analysis that shows how volumes, topics and severity have changed over time. This analysis enhances our ability to monitor momentum over time and to adapt our resources to emerging risks — supporting safer work, protected rights, and reduced environmental impact throughout the value chain.

The report identifies several key findings, including:

1. In 2024, the PSCI community uploaded more audits than ever to the PSCI platform; over 200, demonstrating great progress by PSCI’s members.
2. Health & Safety remains the largest source of findings by volume, reflecting consistent auditor focus on this business-critical and potentially life-threatening topic.
3. Governance and Management Systems increased in relative prominence since 2023, overtaking Environment as a proportion of total findings, reflecting greater auditor focus on risk management, supplier due diligence against international standards, and incident investigation expectations.
4. Human Rights findings show sharper attention to contract worker treatment and alignment with international frameworks.

The report reinforces the PSCI’s role as a catalyst for continuous improvement, equipping suppliers with tools and guidance to enhance practices and adapt to evolving demands.

For more details, access the full report here.